Article info

Download PDFPDF

Effects of a loading dose regimen of three infusions of chimeric monoclonal antibody to tumour necrosis factor α (infliximab) in spondyloarthropathy: an open pilot study
  1. Dr Van den Bosch Email: eric.veys{at}rug.ac.be
View Full Text

Citation

Van den Bosch F, Kruithof E, Baeten D, et al
Effects of a loading dose regimen of three infusions of chimeric monoclonal antibody to tumour necrosis factor α (infliximab) in spondyloarthropathy: an open pilot study

Publication history

  • Accepted March 27, 2000
  • First published June 1, 2000.
Online issue publication 
June 01, 2000

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.